Centers for Disease Control and Prevention Investigations and Technical Assistance
To assist State and local health authorities and other health related organizations in controlling communicable diseases, chronic diseases and disorders, and other preventable health conditions. Investigations and evaluation of all methods of controlling or preventing disease and disability are carried out by providing epidemic aid, surveillance, technical assistance, consultation, and program support; and by providing leadership and coordination of joint national, State, and local efforts. STEPS- To enable communities to reduce the burden of chronic disease, including: preventing diabetes among populations with pre-diabetes; increasing the likelihood that persons with undiagnosed diabetes are diagnosed; reducing complications of diabetes; preventing overweight and obesity; reducing overweight and obesity; and reducing the complications of asthma. STEPS will achieve these outcomes by improving nutrition; increasing physical activity; preventing tobacco use and exposure, targeting adults who are diabetic or who live with persons with asthma; increasing tobacco cessation, targeting adults who are diabetic or who live with persons with asthma; increasing use of appropriate health care services; improving the quality of care; and increasing effective self-management of chronic diseases and associated risk factors. REACH - REACH U.S. supports community coalitions that design, implement, evaluate, and disseminate community-driven strategies to eliminate health disparities Racial and ethnic groups targeted include: African American/Black, American Indian/Alaska Native, Asian, Native Hawaiian/Other Pacific Islander, and Hispanic/Latino. Health priority areas include: breast and cervical cancer; cardiovascular disease; diabetes mellitus; adult/older adult immunization, hepatitis B, and/or tuberculosis; asthma; and infant mortality. Vulnerable Populations: The purpose of this program is to reduce morbidity, premature mortality, and eliminate health disparities associated with diabetes. This will be done by funding organizations to mobilize community partners and assist them to effectively plan, develop,implement, and evaluate community-based interventions to reduce the risk factors that influence the disproportionate burden of diabetes in vulnerable populations borne by many communities in regions across the country.
General information about this opportunity
Last Known Status
Centers For Disease Control and Prevention, Department of Health and Human Services
Type(s) of Assistance Offered
B - Project Grants
Public Health Service Act, Title 42, Section 243, 247b(k)(2), Public Law USC-
Who is eligible to apply/benefit from this assistance?
States, political subdivisions of States, local health authorities, Federally recognized or state recognized American Indian/Alaska Native tribal governments and organizations with specialized health interests may apply. Colleges, universities, private nonprofit and public nonprofit domestic organizations, research institutions, faith-based organizations, and managed care organizations for some specific programs such as Diabetes.
States, political subdivisions of States, local health authorities, and individuals or organizations with specialized health interests will benefit. Colleges, universities, private non-profit and public nonprofit domestic organizations, research institutions, faith-based organizations, and managed care organizations for some specific programs such as Diabetes.
For other grantees, costs will be determined by HHS regulations 45 CFR 74, Subpart Q.
What is the process for applying and being award this assistance?
Preapplication coordination is required. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review. n/a
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Forms and instructions are available in an interactive format on the CDC web site, at the following Internet address: www.cdc.gov/od/pgo/forminfo.htm. To apply for research funding opportunities, use application form PHS 398 (OMB number 0925-0001 rev. 5/2001. Submit the signed original and five copies of your application by mail or express delivery service to: Technical Information Management, CDC Procurement and Grants Office, 2920 Brandywine Road, Atlanta, GA 30341. State and local governments may use Form 5161. An original and two copies must be submitted. This program is subject to the provisions of 45 CFR Parts 74 or 92, as appropriate.
After review and approval, a notice of award is prepared and processed, along with appropriate notification to the public, initial award provides funds for first budget period (usually 12 months) and Notice of Award indicates support recommended for the remainder of project period, allocation of Federal funds by budget categories, and special conditions, if any. However, applicants are encouraged to call CDC for programmatic technical assistance prior to the development and submission of their assistance application.
Contact the headquarters or regional location, as appropriate for application deadlines
Approval/Disapproval Decision Time
From 90 to 120 days. About 120 days from receipt of application.
If additional support is desired to continue a research project beyond the approved project period, an application for competing continuation must be submitted for review in the same manner as a new application. Projects are renewable for periods of 1 to 3 years.
How are proposals selected?
Applications are reviewed on the basis of scientific/technical merit, with attention given to such matters as: (1) The degree to which the applicant satisfies the essential requirements and possesses other desired characteristics, such as depth, breadth, and scientific merit of the overall application relative to the types of research and demonstration projects proposed; (2) clarity of purpose and overall qualifications, adequacy and appropriateness of personnel to accomplish proposed prevention research projects and demonstration projects, and the nation's health priorities and needs; (3) ability to generalize, translate and disseminate to State or local health departments, boards of education and other appropriate national regional, and local public health agencies and organizations; (4) reasonableness of the proposed budget in relation to the work proposed
How may assistance be used?
To strengthen State and local disease prevention and control programs, such as tuberculosis, childhood immunization, and sexually-transmitted diseases. To support national and local programs to combat disability related to epilepsy through education, partnership development, and enhanced communication. Services and program support: Epidemic aid; technical assistance (field studies and investigations of ongoing disease problems; occupational safety and health); consultation; dissemination of technical information; and provision of specialized services and assistance, including responses to public health emergencies. Training: Training State and local health professionals in broad areas of epidemiology, disability, and research programs such as hospital infections, hepatitis, vector-borne diseases, food-borne diseases, epilepsy, and tuberculosis, at the State or other health related organization's request.) To support capacity building, program planning, development, implementation, evaluation, and surveillance for current and emerging chronic disease conditions related to tobacco use. To achieve four Program Goals through community interventions and mobilization; counter-marketing; policy development and implementation, and surveillance and evaluation. Goals include preventing initiation to tobacco use among young people; eliminate exposure to second hand smoke; promote cessation among adults and young people who use tobacco; and identify and eliminate tobacco-related disparities among specific population groups. Lead regional efforts to prevent and reduce the use of tobacco and exposure to secondhand smoke. Conduct evaluations and implementation of culturally relevant and community competent tobacco control and prevention strategies and continue regional capacity building efforts. To address goal four of the National Tobacco Control Program (Identify and Eliminate Tobacco-Related Disparities). To eliminate health disparities among segments of the population, including differences that occur by gender, race or ethnicity, education, income, disability, geographic location, or sexual orientation. Establish a National Network consortium among six priority populations to coordinate and evaluate tobacco control and prevention initiatives through a broad national strategy to prevent and reduce tobacco use and exposure to second hand smoke and to eliminate tobacco-related disparities among priority populations. To provide funding to establish and/or enhance state-based telephone quitlines to provide tobacco cessation telephone counseling to the public at large. To fund projects that address the promotion of cessation among adults and young people who use tobacco (quitlines.) Address at the National level the promotion of cessation among adults and young people who use tobacco (quitlines). To build state arthritis programs that exponentially expand access and use of evidence-based interventions by embedding intervention programs into existing systems, conducting surveillance and data analysis to inform decision making, and developing state-level intervention, policy, and communication focused partnerships that further program goals. To strengthen state oral health programs and public health core capacity and to reduce inequalities in the oral health of targeted populations. To improve state public health programs, including support for program leadership and staff, to monitor oral health risk factors, and for developing and evaluating prevention programs. To support evidenced- based interventions to prevent oral disease, including community water fluoridation and school-based dental sealant programs. To identify and disseminate information on best practices for state and community oral health programs. To assess state programs and provide recommendations to address gaps and weaknesses. To collaborate in development of the National Oral Health Surveillance Systemandtocosponsorthe annual National Oral Health Conference. To develop initiatives related to oral disease prevention and chronic disease and health promotion capacity. To improve and strengthen state oral health infrastructure by providing technical assistance to state health agencies and coalitions, developing and implementing a plan to advance the Surgeon General's National Call to Action to Promote Oral Health. To coordinate the dissemination of comprehensive oral disease prevention information and health promotion programmatic expertise among state and local agencies and public and private sector organizations in the United States. To develop and promote policies to address oral disease prevention for high-risk adults. To identify modifiable barriers to optional care across diverse managed care settings. To promote public awareness and partnership, provide interstitial cystitis (IC) education for the general public and for health care providers, and develop and enhance communication channels to allow for improved interaction and information sharing among those with IC, advocates for persons with IC and their families, those who provide care and services for persons with IC, researchers and public health scientists. To promote public awareness and partnerships, assess the impact and burden of cognitive impairment within states and nationally, describe the characteristics of expanded data on caregivers and care from a public health perspective, provide Alzheimer’s disease and cognitive health education for the general public and health professionals, and develop and enhance communication channels to allow for improved interaction and information sharing about cognitive impairment and Alzheimer’s disease.
What are the requirements after being awarded this opportunity?
Progress reports are required annually. Upon completion of the project, performance reports are required. Interim reporting requirements may be delineated in the FOA.
In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials.
Financial records, supporting documents, statistical records, and all other records pertinent to the project must be kept readily available for review by personnel authorized to examine PHS grant accounts. Records must be maintained for a minimum of 3 years after the end of a budget period. If questions still remain, such as those raised as a result of an audit, records must be retained until completion or resolution of any audit in process or pending resolution. Property records must be retained in accordance with PHS Grants Policy Statement requirements.
Other Assistance Considerations
Formula and Matching Requirements
Statutory formula is not applicable to this assistance listing.
Matching requirements are not applicable to this assistance listing.
MOE requirements are not applicable to this assistance listing.
Length and Time Phasing of Assistance
Assistance is available for a 12-month budget period within project periods ranging from 1 to 5 years. After awards are issued, funds are released in accordance with the payment procedure established by the grantee institution with DHHS, which may be an Electronic Transfer System or a Monthly Cost Request System. Method of awarding/releasing assistance: Lump.
Who do I contact about this opportunity?
Regional or Local Office
DP09-901, DP09-902, DP08-811, HM08-805, DP10-1002, DP11-1105, DP11-004, DP11-004, DP11-005, HM08-805; OE12-1202, OE15-1502
4770 Buford Hwy
Atlanta, GA 30341 US
(Cooperative Agreements) FY 18$6,564,572.00; FY 19 FY 20 est $0.00; FY 17$6,242,247.00; FY 16$6,564,573.00; - Because this is a CDC-wide CFDA# this is to identify the HHS/CDC CSELS/DHIS portion/update for: FY14 ($6,695,957), FY15 ($6,565,572) and FY16 ($6564572) and FY17 (6564572) above
NCCDPHP funding for this NOFO FY16($5,455,639), FY17($5,782,651), FY18($5,481,262) these programs will end FY19.
Range and Average of Financial Assistance
Regulations, Guidelines and Literature
Regulations governing this program are published in the application kit and identified on the notices of award. PHS Grants Policy Statement No. 94-50,000 (Revised) April l, 1994.
Examples of Funded Projects